back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-24 14:30 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,613
+15,234 vol $10.74 each |
83,137 | |
| Filed 2023-05-24 13:53 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
| Filed 2023-05-24 13:49 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,733 vol |
8,733 | |
| Filed 2023-05-24 13:48 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-24 13:47 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
| Filed 2022-05-23 10:46 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
67,903 | |
| Filed 2022-05-23 10:40 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
| Filed 2022-05-23 10:38 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-17 16:56 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$685,322
+53,291 vol $12.86 each |
53,291 | |
| Filed 2021-06-17 16:54 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|